HSCS Q4 EPS Estimate Lifted by Ascendiant Capital Markets

Heart Test Laboratories, Inc. (NASDAQ:HSCS) – Analysts at Ascendiant Capital Markets raised their Q4 2025 earnings per share (EPS) estimates for shares of Heart Test Laboratories in a report released on Tuesday, March 18th. Ascendiant Capital Markets analyst L. Ward now anticipates that the company will post earnings per share of ($2.51) for the quarter, up from their previous forecast of ($2.57). Ascendiant Capital Markets currently has a “Buy” rating and a $14.00 price objective on the stock. The consensus estimate for Heart Test Laboratories’ current full-year earnings is ($10.01) per share. Ascendiant Capital Markets also issued estimates for Heart Test Laboratories’ Q1 2026 earnings at ($2.41) EPS, Q2 2026 earnings at ($2.46) EPS, Q3 2026 earnings at ($2.49) EPS, Q4 2026 earnings at ($2.42) EPS and FY2026 earnings at ($9.78) EPS.

Heart Test Laboratories (NASDAQ:HSCS) last announced its earnings results on Thursday, March 13th. The company reported ($2.57) earnings per share for the quarter, missing analysts’ consensus estimates of ($2.53) by ($0.04).

Separately, Maxim Group reiterated a “buy” rating and issued a $12.00 target price on shares of Heart Test Laboratories in a research report on Wednesday, December 18th.

Heart Test Laboratories Price Performance

Shares of NASDAQ:HSCS opened at $2.91 on Friday. The company’s fifty day moving average price is $3.39 and its 200-day moving average price is $3.42. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.72 and a quick ratio of 1.52. The firm has a market capitalization of $2.85 million, a price-to-earnings ratio of -0.37 and a beta of 2.77. Heart Test Laboratories has a one year low of $2.36 and a one year high of $13.50.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.